Evidence map›Paper›PMID 41112951›Full record

ReviewAdvances in hematology2025

Investigating the Role of HOTAIR and MALAT1 Long Noncoding RNAs and Their Relations With Bone Marrow Environment in Acute Myeloid Leukemia Subtypes: Biomarkers and Treatment Response.

Hero Hamad, Goran Othman, Ranan Kardagh

Abstract readReview
In one paragraph

Review in Advances in hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hero HamadDepartment of Medical Laboratory Technology, Erbil Health and Medical Technical College, Erbil Polytechnic University, Erbil, Iraq.ORCID https://orcid.org/0000-0002-5313-2002
Goran OthmanDepartment of Medical Laboratory Technology, Erbil Health and Medical Technical College, Erbil Polytechnic University, Erbil, Iraq.ORCID https://orcid.org/0000-0002-0880-042X
Ranan KardaghDepartment of Medical Laboratory Technology, Al-Qalam University College, Kirkuk, Iraq.ORCID https://orcid.org/0000-0002-8367-8815

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long noncoding RNAs have recently emerged as major players in cancer by operating through complex structural and functional diversity in a wide range of cellular processes. Among these, certain lncRNAs, including MALAT1 and HOTAIR, have been in the limelight concerning AML for their important roles played in regulating gene expression that in turn influence the disease course of AML. This review summarizes the structure and classification of lncRNAs, mechanisms of action regarding cancer biology, and how lncRNAs such as MALAT1 and HOTAIR act as oncogenes or tumor suppressors. It also examines intricate correlations among these lncRNAs and the bone marrow microenvironment with regard to effects on AML cell proliferation, migration, and survival. In the current review, the key pathways in AML, through which MALAT1 and HOTAIR drive cellular proliferation and epigenetic processes, are discussed in detail to point out possible therapeutic targets. The interactions between MALAT1 and HOTAIR within the bone marrow microenvironment suggest the diverse involvement of lncRNAs in AML and support their applications in biomarker development and as novel avenues for targeted therapies. This review thus represents a broad overview with the intention of furthering our understanding of the lncRNA-mediated pathways in AML and their use as diagnostic and therapeutic tools.

Indexed as

AMLbone marrow environmentHOTAIRLncRNAMALAT1

Identifiers

PMID41112951
PMCPMC12530475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.